相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Adjunctive interferon-γ immunotherapy for the treatment of HIV-associated cryptococcal meningitis: a randomized controlled trial
Joseph N. Jarvis et al.
AIDS (2012)
Evaluation of a Novel Point-of-Care Cryptococcal Antigen Test on Serum, Plasma, and Urine From Patients With HIV-Associated Cryptococcal Meningitis
Joseph N. Jarvis et al.
CLINICAL INFECTIOUS DISEASES (2011)
Primary prophylaxis of cryptococcal disease with fluconazole in HIV-positive Ugandan adults: a double-blind, randomised, placebo-controlled trial
Rosalind Parkes-Ratanshi et al.
LANCET INFECTIOUS DISEASES (2011)
Poor long-term outcomes for cryptococcal meningitis in rural South Africa
Richard J. Lessells et al.
SAMJ SOUTH AFRICAN MEDICAL JOURNAL (2011)
Testing but not treating: missed opportunities and lost lives in the South African antiretroviral therapy programme
Joseph N. Jarvis et al.
AIDS (2010)
Adult meningitis in a setting of high HIV and TB prevalence: findings from 4961 suspected cases
Joseph N. Jarvis et al.
BMC INFECTIOUS DISEASES (2010)
Cryptococcal Antigen Screening for Patients Initiating Antiretroviral Therapy: Time for Action
Joseph N. Jarvis et al.
CLINICAL INFECTIOUS DISEASES (2010)
Cost-Effectiveness of Serum Cryptococcal Antigen Screening to Prevent Deaths among HIV-Infected Persons with a CD4+ Cell Count ≤100 Cells/mL Who Start HIV Therapy in Resource-Limited Settings
David B. Meya et al.
CLINICAL INFECTIOUS DISEASES (2010)
Outcomes of cryptococcal meningitis in antiretroviral naive and experienced patients in South Africa
Joseph N. Jarvis et al.
JOURNAL OF INFECTION (2010)
The role of serum cryptococcal antigen screening for the early diagnosis of cryptococcosis in HIV-infected patients with different ranges of CD4 cell counts
Pannee Pongsai et al.
JOURNAL OF INFECTION (2010)
Treatment of Cryptococcal Meningitis in KwaZulu-Natal, South Africa
Josephine V. J. Lightowler et al.
PLOS ONE (2010)
Cost-Effectiveness of Primary Prophylaxis of AIDS Associated Cryptococcosis in Cambodia
Romain Micol et al.
PLOS ONE (2010)
Estimation of the current global burden of cryptococcal meningitis among persons living with HIV/AIDS
Benjamin J. Park et al.
AIDS (2009)
Screening for Cryptococcal Antigenemia in Patients Accessing an Antiretroviral Treatment Program in South Africa
Joseph N. Jarvis et al.
CLINICAL INFECTIOUS DISEASES (2009)
Early mortality among adults accessing antiretroviral treatment programmes in sub-Saharan Africa
Stephen D. Lawn et al.
AIDS (2008)
Outcomes of cryptococcal meningitis in Uganda before and after the availability of highly active antiretroviral therapy
Andrew Kambugu et al.
CLINICAL INFECTIOUS DISEASES (2008)
High-dose amphotericin B with flucytosine for the treatment of cryptococcal meningitis in HIV-infected patients: A randomized trial
Tihana Bicanic et al.
CLINICAL INFECTIOUS DISEASES (2008)
Corticosteroids for bacterial meningitis in adults in sub-Saharan Africa
Matthew Scarborough et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Prevalence, determinants of positivity, and clinical utility of cryptococcal antigenemia in Cambodian HIV-infected patients
Romain Micol et al.
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES (2007)
Asymptomatic serum cryptococcal antigenemia and early mortality during antiretroviral therapy in rural Uganda
Cheryl A. Liechty et al.
TROPICAL MEDICINE & INTERNATIONAL HEALTH (2007)
Healthcare utilization of patients accessing an African national treatment program
Guy Harling et al.
BMC HEALTH SERVICES RESEARCH (2007)
CD4 decline and incidence of opportunistic infections in Cape Town, South Africa: Implications for prophylaxis and treatment
Charles B. Holmes et al.
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES (2006)
Primary and opportunistic pathogens associated with meningitis in adults in Bangui, Central African Republic, in relation to human immunodeficiency virus serostatus
Claudine Bekondi et al.
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2006)
A multicentre, randomized, double-blind, placebo-controlled trial of primary cryptococcal meningitis prophylaxis in HIV-infected patients with severe immune deficiency
P Chetchotisakd et al.
HIV MEDICINE (2004)
Systematic screening of cryptococcal antigenemia in HIV-positive adults in Uganda
JM Tassie et al.
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES (2003)
The changing epidemiology of cryptococcosis: An update from population-based active surveillance in 2 large metropolitan areas, 1992-2000
SA Mirza et al.
CLINICAL INFECTIOUS DISEASES (2003)
Prevention of human immunodeficiency virus-related opportunistic infections in France: A cost-effectiveness analysis
Y Yazdanpanah et al.
CLINICAL INFECTIOUS DISEASES (2003)
Cryptococcal infection in a cohort of HIV-1-infected Ugandan adults
N French et al.
AIDS (2002)
A controlled trial of itraconazole as primary prophylaxis for systemic fungal infections in patients with advanced human immunodeficiency virus infection in Thailand
S Chariyalertsak et al.
CLINICAL INFECTIOUS DISEASES (2002)
Does long-term itraconazole prophylaxis result in in vitro azole resistance in mucosal Candida albicans isolates from persons with advanced human immunodeficiency virus infection?
M Goldman et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2000)
分享论文
